- Filed
- May 12, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 12, 2026 | 7.02M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 6.69M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 386 sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.44M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$203.53K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $8.8M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $4.98M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $2.14M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $2.74M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.14M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.74M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $9.16M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $5.44M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $10.19M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $6.5M |
| Total Assets restated | Q1 2026 · Mar 31, 2025 | $1.44M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.15 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$761.59 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.15 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$761.59 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $477.58K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $259.63K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $666.41K |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $90.27K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$962.91K |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$293.97K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.13M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$199K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $16.65K |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $154.42K |